Published in Cancer Res on January 01, 1984
Induction of urokinase-type plasminogen activator by UV light in human fetal fibroblasts is mediated through a UV-induced secreted protein. Mol Cell Biol (1987) 1.17
Immunocytochemical localization of urokinase-type plasminogen activator in Lewis lung carcinoma. J Cell Biol (1984) 1.13
Selective growth arrest and phenotypic reversion of prostate cancer cells in vitro by nontoxic pharmacological concentrations of phenylacetate. J Clin Invest (1993) 1.08
Prostate cancer cell-derived urokinase-type plasminogen activator contributes to intraosseous tumor growth and bone turnover. Neoplasia (2008) 0.97
Prognostic role of urokinase-type plasminogen activator in human gliomas. Am J Pathol (1995) 0.91
Fibrinogen degradation product fragment D induces endothelial cell detachment by activation of cell-mediated fibrinolysis. J Clin Invest (1992) 0.82
In vitro inhibition of human sarcoma cells' invasive ability by bis(5-amidino-2-benzimidazolyl)methane--a novel esteroprotease inhibitor. Am J Pathol (1986) 0.78
Effect of dimethyl sulfoxide on human carcinoma cells, inhibition of plasminogen activator synthesis, change in cell morphology, and alteration of response to cholera toxin. Mol Cell Biol (1985) 0.78
Urokinase- and tissue-type plasminogen activators are suppressed by cortisol in the involuting prostate of castrated rats. Biochem J (1990) 0.78
The relationship between inhibition of plasminogen-activator activity and prostatic involution. Biochem J (1988) 0.77
Up-regulation of urokinase-type plasminogen activator in squamous cell carcinoma of human larynx. Br J Cancer (1996) 0.76
Conformational changes in aspartate transcarbamylase. I. Proteolysis of the intact enzyme. J Biol Chem (1968) 5.34
The minimal replicator of Epstein-Barr virus oriP. J Virol (2000) 1.75
Mechanism of activation of human plasminogen by streptokinase. Presence of active center in streptokinase-plasminogen complex. J Biol Chem (1972) 1.74
Constitutive binding of EBNA1 protein to the Epstein-Barr virus replication origin, oriP, with distortion of DNA structure during latent infection. EMBO J (1993) 1.53
Secondary tumors of the prostate. J Urol (1985) 1.48
Comparison of the EBNA1 proteins of Epstein-Barr virus and herpesvirus papio in sequence and function. Virology (1996) 1.37
Change in antibody conformation induced by hapten. Proc Natl Acad Sci U S A (1965) 1.27
Quantitative determination of the binding of epsilon-aminocaproic acid to native plasminogen. J Biol Chem (1978) 1.22
The binding of tranexamic acid to native (Glu) and modified (Lys) human plasminogen and its effect on conformation. J Biol Chem (1979) 1.19
Content and characterization of plasminogen activators in human lung tumors and normal lung tissue. Cancer Res (1980) 1.17
Protein substrate conformation and proteolysis. Proc Natl Acad Sci U S A (1965) 1.16
Localization of plasminogen activators in human colon cancer by immunoperoxidase staining. Cancer Res (1985) 1.15
Comparison of some properties of native (Glu) and modified (Lys) human plasminogen. J Biol Chem (1978) 1.12
Fibrinogenolysis and fibrinolysis with tissue plasminogen activator, urokinase, streptokinase-activated human globulin, and plasmin. Proc Soc Exp Biol Med (1971) 1.12
Plasminogen activator secretion of human tumors in short-term organ culture, including a comparison of primary and metastatic colon tumors. Cancer Res (1983) 1.07
Affinity chromatography of thymidine kinase from a rat colon adenocarcinoma. Prep Biochem (1976) 1.05
The role of hemostasis and fibrinolysis in the metastatic spread of cancer. Semin Thromb Hemost (1984) 1.02
Conformational changes in aspartate transcarbamylase. 3. A functional model for allosteric behavior. J Biol Chem (1971) 1.01
Plasminogen activator activity and composition in human breast cancer. Cancer Res (1982) 1.01
Plasminogen activator content of human colon tumors and normal mucosae: separation of enzymes and partial purification. J Natl Cancer Inst (1980) 0.97
Primary mediastinal germ cell tumors. Histologic patterns of treatment failures at autopsy. Cancer (1988) 0.93
Ligand-induced conformational changes in ribonuclease. J Biol Chem (1968) 0.93
Phosphoenolpyruvate carboxylase of Escherichia coli. Purification and some properties. J Biol Chem (1972) 0.92
Effects of 5-(2-chlorobenzyl)-4,5,6,7-tetrahydrothieno[3,2-c]pyridine hydrochloride (Ticlopidine), a platelet aggregation inhibitor, on blood-borne metastasis. Cancer Res (1981) 0.91
Interference with dimethylhydrazine induction of colon tumors in mice by epsilon-aminocaproic acid. Science (1982) 0.91
Thromboplastic and fibrinolytic activities of cultured human cancer cell lines. Br J Cancer (1979) 0.90
Relationship between DNA ploidy, glandular differentiation, and tumor spread in human prostate cancer. Cancer Res (1985) 0.90
Demonstration of urokinase expression in cancer cells of colon adenocarcinomas by immunohistochemistry and in situ hybridization. Am J Pathol (1999) 0.89
Oxygen Transport. Science (1960) 0.88
Plasminogen activator content of neoplastic and benign human prostate tissues; fibrin augmentation of an activator activity. Int J Cancer (1981) 0.88
Activator activities of the transient forms of the human plasminogen-streptokinase complex during its proteolytic conversion to the stable activator complex. J Biol Chem (1976) 0.87
Evaluation of bladder washings and urine cytology in the diagnosis of bladder cancer and its correlation with selected biopsies of the bladder mucosa. J Urol (1984) 0.86
Prognostic factors in localized prostatic carcinoma. J Urol (1985) 0.86
Esterase activities in the zymogen moiety of the streptokinase-plasminogen complex. J Biol Chem (1974) 0.86
Comparative study of plasminogen activator antigens in colonic carcinomas and adenomas. Int J Cancer (1988) 0.86
Tetracycline resistance in Escherichia coli isolates from hospital patients. Antimicrob Agents Chemother (1975) 0.85
Improved medium for extraction of plasminogen activator from tissue. Prep Biochem (1982) 0.85
Urokinase-like plasminogen activators of unusually high molecular weight secreted by a cell line derived from a human lung cancer case. J Biol Chem (1982) 0.85
Conformational changes in aspartate transcarbamylase. II. Concerted or sequential mechanism? J Biol Chem (1969) 0.84
Directed migration of murine and human tumor cells to collagenases and other proteases. Cancer Res (1989) 0.83
Plasminogen activators in human malignant melanoma. J Natl Cancer Inst (1984) 0.83
Secretion of plasminogen activators by human colorectal and gastric tumor explants. Clin Exp Metastasis (1988) 0.82
Ligand-stabilized conformations in serum albumin. J Biol Chem (1967) 0.81
Tryptic hydrolysis of human serum albumin. The pattern of initial fragmentation. J Biol Chem (1967) 0.80
Thromboplastic and fibrinolytic activities of ascites tumor cells of rats, with reference to their role in metastasis formation. Gan (1978) 0.80
Cancer cells release a covalent complex containing disulfide-linked domains from urinary plasminogen activator, neural cell adhesion molecule, and haptoglobin alpha and beta chains. Arch Biochem Biophys (1997) 0.79
Disseminated necrotizing encephalopathy induced by methotrexate therapy alone. Acta Pathol Jpn (1988) 0.78
Neuroleptanalgesia for patients with kidney malfunction. Anesth Analg (1971) 0.78
Augmentation of streptokinase activator activity by fibrinogen or fibrin. Thromb Res (1980) 0.78
Potentiation of thrombolytic therapy by enzyme combinations and with aspirin or pentoxifylline. J Med (1994) 0.77
Epidermal growth factor and 12-tetradecanoyl phorbol 13-acetate induction of urokinase in A431 cells. Semin Thromb Hemost (1991) 0.77
Plasminogen activator content of human tumor and adjacent normal tissue measured with fibrin and non-fibrin assays. Cancer Res (1986) 0.77
Circulatory effects of analgesic and neuroleptic drugs in patients with chronic renal failure undergoing maintenance dialysis. Br J Anaesth (1970) 0.77
Hypertrophy of the placenta and sacrococcygeal teratoma. Report of two cases. Virchows Arch A Pathol Anat Histol (1980) 0.76
Fibrinolysis-inhibitory activity of cultured human cancer cell lines. Gan (1981) 0.76
Use of intrathecal and epidural morphine for pain relief in patients with malignant diseases: a preliminary report. J Med (1982) 0.76
Histological patterns of treatment failures in testicular neoplasms. J Urol (1985) 0.76
Ultrastructural study of the effects of tranexamic acid and urokinase on metastasis of Lewis lung carcinoma. Br J Cancer (1982) 0.75
Histopathology of bladder cancer and dysplasia. Urology (1984) 0.75
Effects of tranexamic acid and urokinase on hematogenous metastases of Lewis lung carcinoma in mice. Invasion Metastasis (1981) 0.75
The effect of nitrofurantoin on bladder tumor cell lines: in vitro growth and implantation in the cauterized mouse bladder. J Urol (1985) 0.75
Leiomyosarcoma of the inferior vena cava. J Surg Oncol (1982) 0.75
Cardiorespiratory effects of anaesthesia with morphine or fentanyl in chronic renal failure and cerebral toxicity after morphine. Br J Anaesth (1971) 0.75
Role of tumor thromboplastin in the mode of distribution of metastatic foci in the lung. Gan (1979) 0.75
Experimental photodynamic treatment of canine bladder. J Urol (1985) 0.75
Aspiration biopsy of testis: another method for histologic examination. Fertil Steril (1984) 0.75
[The inborn ear fistula in the horse]. Dtsch Tierarztl Wochenschr (1974) 0.75
Renal and cardiodynamic effects of prostaglandins in normal and hypertensive dogs. Surg Forum (1970) 0.75
Effect of electrocautery on serum creatine phosphokinase in surgical patients. J Surg Oncol (1970) 0.75
Biphasic malignant mesothelioma (malignant adenomatoid tumor) of paratesticular tissue. Urology (1984) 0.75
Electrocautery simulating a laboratory effect of myocardial infarction. J Med (1970) 0.75
A new method for plasminogen standardization. Thromb Diath Haemorrh (1968) 0.75
Further evidence for an active center in streptokinase-plasminogen complex; interaction with pancreatic trypsin inhibitor. Biochem Biophys Res Commun (1973) 0.75
The haemodynamic response to chronic renal failure as studied in the azotaemic state. Br J Anaesth (1970) 0.75
Haemodynamic and metabolic responses to superior vena caval hyperalimentation. Anaesthesia (1971) 0.75
Anion-specific effects on the streptokinase activation of human plasminogen. J Biol Chem (1968) 0.75
Bleomycin-induced nodular pulmonary fibrosis masquerading as metastatic testicular cancer. J Urol (1986) 0.75
Cardiovascular responses to hypertonic glucose. An aspect of resuscitation studied in patients with chronic renal failure. Anaesthesia (1971) 0.75
The Valsalva maneuver as a clinical test for circulatory congestion in chronic uremia. J Surg Oncol (1970) 0.75
Conformational changes in aspartate transcarbamylase. IV. Ligand effects on intersubunit interactions. J Biol Chem (1972) 0.75
Cardiodynamic and renal circulatory effects of P-286 in dogs. J Med (1971) 0.75